Bandingkan Harga & Kinerja Ikapharmindo Putramas Tbk. (IKPM) vs Sarana Menara Nusantara Tbk. (TOWR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ikapharmindo Putramas Tbk. dan Sarana Menara Nusantara Tbk.: Ikapharmindo Putramas Tbk. diperdagangkan di Rp181 (kapitalisasi pasar 308,29 M, volume 24 jam 700), sedangkan Sarana Menara Nusantara Tbk. diperdagangkan di Rp382 (kapitalisasi pasar 22,34 T, volume 24 jam 22,62 jt). Perbedaan utamanya: Sarana Menara Nusantara Tbk. jauh lebih besar — sekitar 72,5× kapitalisasi pasar Ikapharmindo Putramas Tbk., dan Sarana Menara Nusantara Tbk. lebih aktif diperdagangkan (22,62 jt vs 700). Mana yang lebih baik tergantung tujuan investasimu.
| IKPM | TOWR | |
|---|---|---|
Kapitalisasi Pasar | 308,29 M | 22,34 T |
Volume | 700 | 22,62 jt |
Lot | 7 | 226,16 rb |
Perputaran | 127,6 rb | 8,58 M |
Harga Rata-rata | 182,29 | 379,42 |
Nilai Transaksi | 127,6 rb | 8,58 M |
Harga Ekuilibrium Indikatif | 183 | 376 |
Volume Ekuilibrium Indikatif | 100 | 43,99 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Selengkapnya di halaman IKPM →Tentang Sarana Menara Nusantara Tbk.
PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Selengkapnya di halaman TOWR →
